Featured Research

from universities, journals, and other organizations

Hybrid revascularization effective for left main coronary blockages

Date:
March 15, 2010
Source:
Emory University
Summary:
Hybrid revascularization is a combination of coronary artery bypass surgery and percutaneous coronary intervention.

The left main coronary artery provides most of the blood to the heart, and current guidelines call for patients with blockages in this artery to undergo bypass surgery.

Related Articles


Hybrid revascularization is a combination of coronary artery bypass surgery and percutaneous coronary intervention (PCI). Emory physicians have been performing these procedures "off-pump" in a minimally invasive fashion, without breaking open the chest. This technique is also known as "endo-ACAB" (endoscopic atraumatic coronary artery bypass).

Syed Tanveer Rab, MD, assistant professor of medicine (cardiology), Emory University School of Medicine, will report on outcomes from 21 Emory patients with blockages in the left main coronary artery treated using hybrid revascularization.

The presentation took place at the American College of Cardiology meeting in Atlanta on March 15.

Rab describes the Emory approach as a "best of both worlds strategy": minimally invasive off-pump left internal mammary artery (LIMA) graft, plus a stent placed via ultrasound from the left main to the left circumflex artery.

For these patients, the average ICU stay was 1.1 0.4 days. Fifteen patients had hybrid surgery and PCI in the same hospitalization and the rest had the two procedures a few days apart. All but one patient received a drug eluting stent. Two had re-exploration with blood transfusion. No major adverse cardiac or cerebrovascular events were reported in the hospital or after 30 days.

The authors conclude: "Hybrid revascularization for left main coronary artery stenosis appears to be a safe and feasible procedure in selected patients and may preserve the survival advantage imparted by the left internal mammary artery graft to the left anterior descending artery. A multicenter trial to assess intermediate and long term outcomes of this form of hybrid revascularization is warranted."

Emory, Columbia University and Albert Einstein College of Medicine recently received a $1 million "Challenge" grant from the National Heart, Lung and Blood Institute to plan a large-scale clinical trial of hybrid revascularization.

Emory's investigator on this grant is John Puskas, MD, professor of surgery and associate chief, division of cardiothoracic surgery at Emory University School of Medicine.


Story Source:

The above story is based on materials provided by Emory University. Note: Materials may be edited for content and length.


Journal Reference:

  1. T.A. Vassiliades et al. Clinical Outcomes After Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass: A Prospective Evaluation. Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery, 2009; 4 (6): 299 DOI: 10.1097/IMI.0b013e3181bbfa96

Cite This Page:

Emory University. "Hybrid revascularization effective for left main coronary blockages." ScienceDaily. ScienceDaily, 15 March 2010. <www.sciencedaily.com/releases/2010/03/100315161923.htm>.
Emory University. (2010, March 15). Hybrid revascularization effective for left main coronary blockages. ScienceDaily. Retrieved April 1, 2015 from www.sciencedaily.com/releases/2010/03/100315161923.htm
Emory University. "Hybrid revascularization effective for left main coronary blockages." ScienceDaily. www.sciencedaily.com/releases/2010/03/100315161923.htm (accessed April 1, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, April 1, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Sees Resurgence of Drug Trafficking as Ebola Wanes

Liberia Sees Resurgence of Drug Trafficking as Ebola Wanes

AFP (Apr. 1, 2015) The governments of Liberia and Sierra Leone have been busy fighting the menace created by the deadly Ebola virus, but illicit drug lords have taken advantage of the situation to advance the drug trade. Duration: 01:12 Video provided by AFP
Powered by NewsLook.com
Stigma Stalks India's Leprosy Sufferers as Disease Returns

Stigma Stalks India's Leprosy Sufferers as Disease Returns

AFP (Apr. 1, 2015) The Indian government declared victory over leprosy in 2005, but the disease is making a comeback in some parts of the country, with more than a hundred thousand lepers still living in colonies, shunned from society. Duration: 02:41 Video provided by AFP
Powered by NewsLook.com
7-Year-Old Girl Gets 3-D Printed 'robohand'

7-Year-Old Girl Gets 3-D Printed 'robohand'

AP (Mar. 31, 2015) Although she never had much interest in prosthetic limbs before, Faith Lennox couldn&apos;t wait to slip on her new robohand. The 7-year-old, who lost part of her left arm when she was a baby, grabbed it as soon as it came off a 3-D printer. (March 31) Video provided by AP
Powered by NewsLook.com
Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins